These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23388172)

  • 21. [The role of transmembrane lipidtransporter molecules in the atherosclerotic process].
    Harangi M; Köbling T; Paragh G
    Orv Hetil; 2006 Feb; 147(6):251-7. PubMed ID: 16610615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.
    Rust S; Rosier M; Funke H; Real J; Amoura Z; Piette JC; Deleuze JF; Brewer HB; Duverger N; Denèfle P; Assmann G
    Nat Genet; 1999 Aug; 22(4):352-5. PubMed ID: 10431238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of ABCA1 function in transgenic mice.
    Joyce C; Freeman L; Brewer HB; Santamarina-Fojo S
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):965-71. PubMed ID: 12615681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations.
    Koseki M; Matsuyama A; Nakatani K; Inagaki M; Nakaoka H; Kawase R; Yuasa-Kawase M; Tsubakio-Yamamoto K; Masuda D; Sandoval JC; Ohama T; Nakagawa-Toyama Y; Matsuura F; Nishida M; Ishigami M; Hirano K; Sakane N; Kumon Y; Suehiro T; Nakamura T; Shimomura I; Yamashita S
    J Atheroscler Thromb; 2009 Jun; 16(3):292-6. PubMed ID: 19556721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activity.
    Kim WS; Hill AF; Fitzgerald ML; Freeman MW; Evin G; Garner B
    J Alzheimers Dis; 2011; 27(2):441-52. PubMed ID: 21860089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.
    Clee SM; Kastelein JJ; van Dam M; Marcil M; Roomp K; Zwarts KY; Collins JA; Roelants R; Tamasawa N; Stulc T; Suda T; Ceska R; Boucher B; Rondeau C; DeSouich C; Brooks-Wilson A; Molhuizen HO; Frohlich J; Genest J; Hayden MR
    J Clin Invest; 2000 Nov; 106(10):1263-70. PubMed ID: 11086027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects.
    Fobker M; Voss R; Reinecke H; Crone C; Assmann G; Walter M
    FEBS Lett; 2001 Jul; 500(3):157-62. PubMed ID: 11445077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux.
    Utech M; Höbbel G; Rust S; Reinecke H; Assmann G; Walter M
    Biochem Biophys Res Commun; 2001 Jan; 280(1):229-36. PubMed ID: 11162504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis.
    Ishii J; Nagano M; Kujiraoka T; Ishihara M; Egashira T; Takada D; Tsuji M; Hattori H; Emi M
    J Hum Genet; 2002; 47(7):366-9. PubMed ID: 12111371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.
    Slatter TL; Williams MJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Morison IM; McCormick SP
    Atherosclerosis; 2006 Aug; 187(2):393-400. PubMed ID: 16225879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease.
    Negi SI; Brautbar A; Virani SS; Anand A; Polisecki E; Asztalos BF; Ballantyne CM; Schaefer EJ; Jones PH
    J Clin Lipidol; 2013; 7(1):82-7. PubMed ID: 23351586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1.
    Lhermusier T; Severin S; Van Rothem J; Garcia C; Bertrand-Michel J; Le Faouder P; Hechler B; Broccardo C; Couvert P; Chimini G; Sié P; Payrastre B
    J Thromb Haemost; 2016 Mar; 14(3):585-95. PubMed ID: 26749169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency.
    Nishida Y; Hirano K; Tsukamoto K; Nagano M; Ikegami C; Roomp K; Ishihara M; Sakane N; Zhang Z; Tsujii Ki K; Matsuyama A; Ohama T; Matsuura F; Ishigami M; Sakai N; Hiraoka H; Hattori H; Wellington C; Yoshida Y; Misugi S; Hayden MR; Egashira T; Yamashita S; Matsuzawa Y
    Biochem Biophys Res Commun; 2002 Jan; 290(2):713-21. PubMed ID: 11785958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1.
    Stukas S; May S; Wilkinson A; Chan J; Donkin J; Wellington CL
    Biochim Biophys Acta; 2012 Mar; 1821(3):536-46. PubMed ID: 21889608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels.
    Villard EF; EI Khoury P; Frisdal E; Bruckert E; Clement K; Bonnefont-Rousselot D; Bittar R; Le Goff W; Guerin M
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):822-8. PubMed ID: 23372063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced platelet count, but no major platelet function abnormalities, are associated with loss-of-function ATP-binding cassette-1 gene mutations.
    Minuz P; Meneguzzi A; Femia EA; Fava C; Calabria S; Scavone M; Benati D; Poli G; Zancanaro C; Calandra S; Lucchi T; Cattaneo M
    Clin Sci (Lond); 2017 Aug; 131(16):2095-2107. PubMed ID: 28634189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1.
    El Khoury P; Couvert P; Elbitar S; Ghaleb Y; Abou-Khalil Y; Azar Y; Ayoub C; Superville A; Guérin M; Rabès JP; Varret M; Boileau C; Jambart S; Giral P; Carrié A; Le Goff W; Abifadel M
    J Clin Lipidol; 2018; 12(6):1374-1382. PubMed ID: 30361172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects.
    Attia N; Ramaharo A; Paul JL; Cambillau M; Beaune P; Grynberg A; Simon A; Fournier N
    Atherosclerosis; 2008 May; 198(1):49-56. PubMed ID: 17980882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family.
    Maranghi M; Truglio G; Gallo A; Grieco E; Verrienti A; Montali A; Gallo P; Alesini F; Arca M; Lucarelli M
    Biochem Biophys Res Commun; 2019 Jan; 508(2):487-493. PubMed ID: 30503498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.